Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

0% Complete

Course Content

Management of Adverse Events of Check Point Inhibitors (CPI) and Antibody Drug Conjugates (ADC) in Solid Tumors

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration: 0.00 hour
Released: May 14, 2025
Last Review: May 14, 2025
Expires: May 14, 2028

Faculty & Disclosure

Faculty

Meri Muminovic, MD

Disclosure

Meri Muminovic, MD discloses no such relationships exist

Accreditation

NA

Related Courses

2026 MCM | Applications of MRD Concept in Solid Tumors

2026 MCM | Applications of MRD Concept in Solid Tumors

2026 MCM | What Do You Need to Know About ADC Toxicity in Solid Tumors? Most Common Adverse Events

2026 MCM | What Do You Need to Know About ADC Toxicity in Solid Tumors? Most Common Adverse Events

Explore More Courses